ERBB2 and bladder transitional cell carcinoma: Human epidermal growth factor receptor 2 (HER2) expression was evaluated using immunohistochemistry (IHC), and its association with clinicopathological features was analyzed.<h4>Results</h4>Among the 237 patients, 69 (29.1%) had bladder urothelial carcinoma complicated by IPCa.